Cancer cells cooperate to fight off the immune system and overcome therapy
New research from the lab of Thomas Gajewski, MD, PhD, showed that tumor cells can escape T cell killing during immunotherapy by using “clonal cooperation.” This work suggests that early treatment with immunotherapies may be more effective, before tumor cell heterogeneity emerges.
New nanotechology design provides hope for personalized vaccination for treating cancer
New nanoscale metal-organic framework design leverages radiation treatment and the adaptive immune response to deliver multi-pronged cancer therapy.
After years of treatment and three relapses, CAR T-cell therapy offers hope for leukemia patient
Jacelyn Walsh, a 41-year-old mother of two, relapsed three times in her battle with acute lymphoblastic leukemia. After trying CAR T-cell therapy at UChicago Medicine, she has hope for the future.
